Please assess the completion status of the following clinical trial:

Trial Title: Promotion of Coronary Collateral Function by Ivabradine-Induced Bradycardia in Patients With Coronary Artery Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age \> 18 years old~2. 1- to 3-vessel stable coronary artery disease (CAD)~3. At least 1 stenotic lesion suitable for PCI~4. No Q-wave myocardial infarction in the area undergoing CFI measurement~5. Written informed consent to participate in the study~Exclusion Criteria:~1. Acute coronary syndrome~2. CAD treated best by surgical coronary bypass~3. Indications for BB treatment (heart failure, arrhythmias, \<3months post-infarct)~4. RHR \<60/min without any treatment~5. Sick sinus syndrome, sinuatrial block or \>2nd degree atrio-ventricular block~6. Atrial fibrillation~7. Inherited or acquired long-QT syndrome~8. Indwelling pacemaker~9. Severe hepatic or renal failure (creatinine clearance \<15ml/min)~10. Hypersensitivity against ivabradine or adjuvants~11. Pre-menopausal women

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Collateral promotion; PCI after 6 months (Type: EXPERIMENTAL): None
- Collateral promotion; PCI at baseline (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).